MedTrace Logo

Phyllantus Amarus for the Protection of Liver Health

NCT03349697 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2017-11-27

No results posted yet for this study

Summary

This study is a randomized, double-blind, placebo controlled crossover study. The purpose of this study is to assess the ability of Phyllantus amarus to protect the liver against temporary stress including oxidative stress induced by alcohol consumption.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Phyllantus amarus

OTHER

Placebo

Sponsors & Collaborators

  • Biotropics Malaysia Berhad

    lead INDUSTRY

Principal Investigators

  • Tengku Shahrir Tengku Adnan · Biotropics Malaysia Berhad

  • Sanjay Udani, MD · Medicus Research, LLC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-13
Primary Completion
2010-10-16
Completion
2010-10-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03349697 on ClinicalTrials.gov